Legal Opinion
In Re Lorazepam & Clorazepate Antitrust Litigation
Court of Appeals for the D.C. Circuit
Decided May 14, 2002No. 01-7163PublishedCited by 80 opinions
1Opinion of the Court
Opinion for the Court filed by Circuit Judge ROGERS.
ROGERS, Circuit Judge:
This appeal presents for the first time in this circuit the threshold question of when interlocutory review of a class certification decision is appropriate under Federal Rule of Civil Procedure 23(f). We take the opportunity to offer general guidance on the scope of our discretion under Rule 23(f) in considering the petition for Rule 23(f) review by Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., UDL Laboratories, Inc., Profarmaco S.r.L, Cambrex Corporation, and GYMA Laboratories of America, Inc. (collectively…
2Cases cited19 opinions
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- General Telephone Co. of Southwest v. FalconSupreme Court of the United States · 1982
- Eisen v. Carlisle & JacquelinSupreme Court of the United States · 1974
- Associated General Contractors of California, Inc. v. California State Council of CarpentersSupreme Court of the United States · 1983
- Illinois Brick Co. v. IllinoisSupreme Court of the United States · 1977
14 more not listed; retrieve them via the Exa API.
3Cited by80 opinions
- Lerner v. Fleet Bank, N.A.Court of Appeals for the Second Circuit · 2003
- Julie Olden, Richard Hunter, Wilbur Bleau, and All Others Similarly Situated v. Lafarge Corp.Court of Appeals for the Sixth Circuit · 2004
- In Re Rail Freight Fuel Surcharge Antitrust LitigationCourt of Appeals for the D.C. Circuit · 2013
- Vallario v. VandeheyCourt of Appeals for the Tenth Circuit · 2009
- Garcia, Guadalupe L. v. Johanns, MichaelCourt of Appeals for the D.C. Circuit · 2006
75 more not listed; retrieve them via the Exa API.